1058 GMT - EssilorLuxottica's purchase of Cellview Imaging marks the second acquisition in ophthalmology diagnostics for the European eyecare giant as it pushes into this and other subcategories, RBC Capital Markets' Piral Dadhania says in a note. The Ray-Ban maker said it is buying Canadian startup Cellview, which offers diagnostics via retinal imaging, for an undisclosed sum. The deal follows EssilorLuxottica's July acquisition of Heidelberg Engineering, another ophthalmology diagnostics company, and strengthens its offering, RBC says. EssilorLuxottica is pursuing a structural expansion into selective ophthalmology subcategories, with a move into diagnostics already in progress and potentially in cataracts and contact lenses down the line, the analyst says. Shares rise 1.1%. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

February 11, 2025 05:58 ET (10:58 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.